Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 680.97M | 696.16B | 657.27M | 691.32M | 777.55M | 656.90M |
Gross Profit | 161.15M | 161.00B | 171.92M | 199.54M | 268.56M | 204.54M |
EBITDA | 45.70M | 33.96M | 50.00M | 65.74M | 144.89M | 116.76M |
Net Income | -22.65M | -96.98M | -11.08M | 12.36M | 453.16M | 58.12M |
Balance Sheet | ||||||
Total Assets | 1.12B | 1.03B | 1.15B | 1.20B | 1.30B | 918.57M |
Cash, Cash Equivalents and Short-Term Investments | 169.36M | 153.50M | 175.13M | 195.19M | 314.35M | 202.41M |
Total Debt | 54.78M | 50.91M | 67.21M | 78.80M | 98.77M | 201.56M |
Total Liabilities | 230.08M | 210.36M | 253.41M | 315.82M | 444.54M | 402.25M |
Stockholders Equity | 886.29M | 822.33M | 891.61M | 883.92M | 854.09M | 373.20M |
Cash Flow | ||||||
Free Cash Flow | 9.44M | 29.67B | -11.38M | -89.95M | 80.85M | 56.04M |
Operating Cash Flow | 39.62M | 29.67B | 25.71M | 20.47M | 218.87M | 128.74M |
Investing Cash Flow | -29.32M | -36.44B | -35.74M | -109.63M | -130.82M | -72.54M |
Financing Cash Flow | -15.25M | -15.50B | -9.90M | -29.61M | 21.85M | -18.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥243.52B | 15.34 | 6.64% | 2.42% | 9.16% | -0.15% | |
58 Neutral | $548.63M | 113.03 | 0.66% | 5.42% | 0.15% | -92.08% | |
54 Neutral | $785.52M | ― | -11.32% | ― | 5.92% | -746.07% | |
54 Neutral | $927.10M | ― | -10.09% | ― | -21.27% | -207.30% | |
50 Neutral | $541.17M | ― | -3.81% | ― | 7.71% | -44.25% | |
48 Neutral | $1.42B | ― | -50.93% | ― | 77.94% | -75.13% | |
46 Neutral | $633.00M | ― | -2.98% | ― | 15.45% | 49.82% |
On July 14, 2025, Alpha and Omega Semiconductor Limited announced an agreement to sell approximately 20.3% of its equity interest in its joint venture CQJV, located in Chongqing, China, to a strategic investor for $150 million. This transaction, expected to close by the end of 2025, will provide AOS with capital to invest in technology and R&D, while maintaining its business relationship with CQJV. The sale aligns with AOS’s strategy to monetize its investments and reinvest in expanding its product portfolio, ensuring continued access to CQJV’s manufacturing capabilities.